Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report
about
Shift work and pathological conditionsDecay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis casesInterferon-gamma release assay (modified QuantiFERON) as a potential marker of infection for Leishmania donovani, a proof of concept studyDiagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning.Prevalence of abnormal radiological findings in health care workers with latent tuberculosis infection and correlations with T cell immune response.T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data.Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workersTuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers.Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.Kinetics of a tuberculosis-specific gamma interferon release assay in military personnel with a positive tuberculin skin test.Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatmentWithin-subject interlaboratory variability of QuantiFERON-TB gold in-tube testsDetermining Mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing.Effect of isoniazid on antigen-specific interferon-γ secretion in latent tuberculosis.Low sensitivity of T-cell based detection of tuberculosis among HIV co-infected Tanzanian in-patients.Prevalence of latent tuberculosis infection and associated risk factors in an urban African setting.Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot studyNosocomial tuberculosis in IndiaConsistency of Mycobacterium tuberculosis-specific interferon-gamma responses in HIV-1-infected women during pregnancy and postpartum.Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individualsQuantiFERON-TB Gold and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Children.Factors Affecting Mortality and Treatment Completion of Tuberculosis Patients in Isfahan Province from 2006 to 2011.Peripheral blood gamma interferon release assays predict lung responses and Mycobacterium tuberculosis disease outcome in miceLevels of interferon-gamma increase after treatment for latent tuberculosis infection in a high-transmission setting.Circulating Interferon-Gamma Levels Are Associated with Low Body Weight in Newly Diagnosed Kenyan Non-Substance Using Tuberculosis Individuals.Evaluation of the effect of treatment of latent tuberculosis infection on QuantiFERON-TB gold assay resultsThe Prevalence of Tb in HIV Patients and Risk Factor With Frequent Referral (Iran, 2009-10).Update in tuberculosis 2006.Current issues on molecular and immunological diagnosis of tuberculosis.QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection.Administrative measures for preventing Mycobacterium tuberculosis infection among healthcare workers in a teaching hospital in Rio de Janeiro, BrazilEvaluation of the tuberculin skin test and the interferon-gamma release assay for TB screening in French healthcare workers.Variability of the QuantiFERON®-TB gold in-tube test using automated and manual methods.Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.Use of the QuantiFERON-TB Gold In-Tube Test in the Diagnosis and Monitoring of Treatment Efficacy in Active Pulmonary Tuberculosis.Tuberculosis in liver transplant recipients: experience of a South Indian liver transplant center.Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.
P2860
Q28392766-33E440C5-2676-4CEC-9FB9-639AEF07E150Q28475371-666E6B73-5723-4FA6-8594-80BB23CAB571Q28477803-43FB0787-6B46-49B1-BE90-0EC557273460Q30979334-8D0F70D2-264F-4A59-9AF6-775D445A7302Q33293104-A0D9F2A9-29E4-4C4B-9FC0-BDB70C5575F1Q33295392-C2033066-4C93-4005-813B-BB2A0520CAEFQ33325475-724612E1-DF1B-4AFA-B156-BFAB3C5E686EQ33496134-9880CD9E-D269-48A7-87A1-D89E39B2125EQ33567995-C969E989-E006-481D-901C-08C0724F7430Q33591688-339259C1-BB74-4C16-AA50-E80DD0D2446AQ33638976-E4E0C1CC-1DFE-4ADC-8FBF-929186F7FCF6Q33807147-C4C49D55-E0EC-449B-A95F-DCDB4E7DD1FEQ33909191-7364139A-8CC6-4A6A-9ED7-2068587DCFC9Q34185319-7B3B949D-1B5C-4AA1-9458-6ED03A262FE2Q34412119-C3BE8C77-F6A7-4802-9F74-7F0CFA98339FQ34450737-7187AF39-4FA7-49DC-98B6-31A77BA818FDQ35054208-4FB82827-D334-4D83-94CA-1D87CBF3B76DQ35201537-DE365B84-F6F0-44BE-8998-FA25984E0A1BQ35357927-1475914C-883E-4351-BCF2-4947510D52CAQ35629697-8D3D83C0-E32A-4C52-9FA7-4BF1E75EC60BQ35805748-BA32A183-CA60-47AA-9135-0929AAD003FEQ35852451-922A4E98-E4D2-4543-9132-0EC544276C4CQ35855200-3BFAC952-2915-4ADD-A351-2D35FBD059CCQ36053408-479040C1-3186-4902-BAF2-F77E7075F9B1Q36120834-B125FFD6-4F00-4180-8C9B-3D40D3F4DDB8Q36497632-234474E7-12C1-41AD-8593-6F02F65D1859Q36516077-84A69184-F693-4A88-8263-60BB2E1F42F2Q36530288-DABE2B64-A7DB-4CB1-AADE-C7E8207A890AQ36606393-5F123030-93E9-4697-B61B-4FA3493CCD4BQ36660943-7EC2C93C-A3AC-461C-864A-4799B5831966Q36753136-8DE08245-9415-4553-9D36-264A7F346DE2Q36861562-A05976F9-1254-4F72-80EE-B5490273DF59Q37206147-2C0EDC30-1177-4182-A3D0-A1F973FB6F35Q37332211-9AAE95A3-4337-4E3E-A87F-A786E952F845Q37465712-A38B4250-D89E-4DAF-9816-9D85E14F5022Q37510309-9F2F3BF8-1930-40CE-8A75-46E9B439FDD7Q37544916-E0C46991-ED14-4263-85B1-FB948C5E3D44Q37724458-43AE7B64-3B48-4C94-88A3-97AE6862E470Q38208758-365C3C51-FCA4-47E4-953C-07DB966B556EQ42252749-893B7E30-ADD0-4900-A0FF-DB3CAF1264CF
P2860
Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Persistently elevated T cell i ...... in India: a preliminary report
@ast
Persistently elevated T cell i ...... in India: a preliminary report
@en
Persistently elevated T cell i ...... in India: a preliminary report
@nl
type
label
Persistently elevated T cell i ...... in India: a preliminary report
@ast
Persistently elevated T cell i ...... in India: a preliminary report
@en
Persistently elevated T cell i ...... in India: a preliminary report
@nl
prefLabel
Persistently elevated T cell i ...... in India: a preliminary report
@ast
Persistently elevated T cell i ...... in India: a preliminary report
@en
Persistently elevated T cell i ...... in India: a preliminary report
@nl
P2093
P2860
P50
P921
P356
P1476
Persistently elevated T cell i ...... in India: a preliminary report
@en
P2093
Deepak K Mendiratta
Rajnish Joshi
Sandeep Dogra
P2860
P2888
P356
10.1186/1745-6673-1-7
P577
2006-05-23T00:00:00Z
P5875
P6179
1043337548